Literature DB >> 23777428

Heparanase-1 and components of the hedgehog signalling pathway are increased in untreated alveolar orbital rhabdomyosarcoma.

Wei-Qiang Tang1, Yan Hei, Li Kang, Li-Hua Xiao.   

Abstract

BACKGROUND: To assess the activities of heparanase-1 and elements of the hedgehog signalling pathway in alveolar orbital rhabdomyosarcoma.
METHODS: Specimens (n = 23) were divided into two groups, those from patients with preoperative chemoradiotherapy or untreated patients; six samples of normal extraocular muscle were used as a normal muscle group. The presence of heparanase-1, patched, smoothened and glioma-associated oncogene homologue-1 protein expression was determined in 23 cases of archival paraffin-embedded alveolar orbital rhabdomyosarcoma after immunohistochemistry. RNA was extracted from three groups of paraffin-embedded specimens and messenger RNA expressions of heparanase-1, smoothened and glioma-associated oncogene homologue-1 compared using nested reverse transcriptase polymerase chain reaction and a limiting dilution analysis.
RESULTS: The heparanase-1, patched, smoothened and glioma-associated oncogene homologue-1 protein was expressed in 91.3%, 87.0%, 91.3% and 78.3%, respectively, of the alveolar orbital rhabdomyosarcoma specimens. Untreated rhabdomyosarcoma samples tended to stain intensely, but staining was relatively weak in tissue obtained from the chemoradiotherapy group. The expression levels of heparanase-1, smoothened and glioma-associated oncogene homologue-1 messenger RNA in untreated and chemoradiotherapy groups paralleled that seen with immunology, and there were no significant differences in heparanase-1, smoothened and glioma-associated oncogene homologue-1 messenger RNA levels between the chemoradiotherapy group and the normal muscle group (P > 0.05). However, the messenger RNA in the untreated group were all significantly higher than those in the chemoradiotherapy and normal muscle groups (P < 0.01).
CONCLUSIONS: Both heparanase-1 and hedgehog signalling pathway are involved in the pathogenesis of alveolar orbital rhabdomyosarcoma; however, chemotherapy and/or radiotherapy appears to significantly inhibit their upregulation.
© 2013 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  hedgehog; heparanase-1; orbital rhabdomyosarcoma.

Mesh:

Substances:

Year:  2013        PMID: 23777428     DOI: 10.1111/ceo.12139

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  3 in total

1.  Heparanase-1 is downregulated in chemoradiotherapy orbital rhabdomyosarcoma and relates with tumor growth as well as angiogenesis.

Authors:  Wei-Qiang Tang; Yan Hei; Jing Lin
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

2.  Encouraging Early Outcomes of Treatment With Arsenic Trioxide Combined With Chemotherapy for Alveolar Rhabdomyosarcoma in Children: 4 Case Reports.

Authors:  Xiaomin Peng; Xilin Xiong; Yang Li; Chuchu Feng; Hongyan Liu; Pingping Wu; Chunmou Li; Wenjun Weng
Journal:  Front Oncol       Date:  2021-10-29       Impact factor: 6.244

3.  Excellent Early Outcomes of Combined Chemotherapy With Arsenic Trioxide for Stage 4/M Neuroblastoma in Children: A Multicenter Nonrandomized Controlled Trial.

Authors:  Chunmou Li; Xiaomin Peng; Chuchu Feng; Xilin Xiong; Jianxin Li; Ning Liao; Zhen Yang; Aiguo Liu; Pingping Wu; Xuehong Liang; Yunyan He; Xin Tian; Yunbi Lin; Songmi Wang; Yang Li
Journal:  Oncol Res       Date:  2021-04-15       Impact factor: 5.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.